Axitinib Impurity F; Dihydro-Axitinib

Axitinib Impurity F; Dihydro-Axitinib

GA01208 - 95%

In stock

Delivery: 3 to 5 working days

Others quantities on request

Specifications

CAS RN: 1443118-73-7
Purity: 95%
Mol Formula: C22H20N4OS
Mol Weight: 388.49
Tags: Pharmaceutical Reference Substances and Impurities ; Axitinib ;

Description

GA01208

Axitinib is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models[3] and has shown partial responses in clinical trials with renal cell carcinoma (RCC)[4] and several other tumour types.

We have successfully synthesized standards of the Axitinib. This will be of interest to pharmaceutical companies and analytical labs.

Wikipedia
Additional information

Packing Unit
25 mg, 50 mg